Login / Signup

Gadolinium-based Contrast Agents Improve Detection of Recurrent Soft-Tissue Sarcoma at MRI.

Behrang AminiWilliam A MurphyTamara Miner HaygoodRajendra KumarKevin W McEneryJohn E MadewellBilal M MujtabaWei WeiColleen M Costelloe
Published in: Radiology. Imaging cancer (2020)
Gadolinium-based contrast agents improved diagnostic performance in detection of recurrent soft-tissue sarcoma. Addition of fat-saturated T2-weighted images provided modest improvement in sensitivity.Keywords: Efficacy Studies, MR-Contrast Agent, Oncology, Soft Tissues/Skin© RSNA, 2020.
Keyphrases